Bouza, Emilio

Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America.

Mermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases

Central Venous Catheters and HemodialysisInfective Endocarditis Diagnosis and Management

Cited by 3,638

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 1,556

European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults

van Prehn, J., Reigadas, E., Vogelzang, E. H., Bouza, E., Hristea, A., Guery, B., Krutova, M., Norén, T., Allerberger, F., Coia, J. E., et al. (2021) · Clinical Microbiology and Infection

Clostridium difficile and Clostridium perfringens researchBacterial Identification and Susceptibility Testing

Cited by 640

Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease

Munoz, P., Bouza, E., Cuenca-Estrella, M., Eiros, J. M., Perez, M. J., Sanchez-Somolinos, M., Rincon, C., Hortal, J., & Pelaez, T. (2005) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 462

Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: Incidence, risk factors, and outcome

Guinea, J., Torres-Narbona, M., Gijón, P., Muñoz, P., Pozo, F., Peláez, T., de Miguel, J., & Bouza, E. (2010) · Clinical Microbiology and Infection

Antifungal resistance and susceptibilityAsthma and respiratory diseases

Cited by 397

The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: An analysis from the ICE Prospective Cohort Study (ICE-PCS)

Dickerman, S. A., Abrutyn, E., Barsic, B., Bouza, E., Cecchi, E., Moreno, A., Doco-Lecompte, T., Eisen, D. P., Fortes, C. Q., Fowler, V. G., et al. (2007) · American Heart Journal

Infective Endocarditis Diagnosis and ManagementCardiac Valve Diseases and Treatments

Cited by 374

Non-HACEK Gram-Negative Bacillus Endocarditis

Morpeth, S., Murdoch, D., Cabell, C. H., Karchmer, A. W., Pappas, P., Levine, D., Nacinovich, F., Tattevin, P., Fernández-Hidalgo, N., Dickerman, S., et al. (2007) · Annals of Internal Medicine

Infective Endocarditis Diagnosis and ManagementOcular Infections and Treatments

Cited by 302

Impact of Early Valve Surgery on Outcome of Staphylococcus aureus Prosthetic Valve Infective Endocarditis: Analysis in the International Collaboration of Endocarditis–Prospective Cohort Study

Chirouze, C., Alla, F., Fowler, V. G., Sexton, D. J., Corey, G. R., Chu, V. H., Wang, A., Erpelding, M.-L., Durante-Mangoni, E., Fernández-Hidalgo, N., et al. (2015) · Clinical Infectious Diseases

Infective Endocarditis Diagnosis and ManagementCardiac Valve Diseases and Treatments

Cited by 104

A Contemporary Picture of Enterococcal Endocarditis

Pericàs, J. M., Llopis, J., Muñoz, P., Gálvez-Acebal, J., Kestler, M., Valerio, M., Hernández-Meneses, M., Goenaga, M. Á., Cobo-Belaustegui, M., Montejo, M., et al. (2020) · Journal of the American College of Cardiology

Infective Endocarditis Diagnosis and ManagementCardiac Valve Diseases and Treatments

Cited by 99

Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit

Muñoz, P., Burillo, A., & Bouza, E. (2000) · International Journal of Antimicrobial Agents

Antifungal resistance and susceptibilityOcular Infections and Treatments

Cited by 95

Correlation between the Elastase Activity Index and Invasiveness of Clinical Isolates of Aspergillus fumigatus

Blanco, J. L., Hontecillas, R., Bouza, E., Blanco, I., Pelaez, T., Muñoz, P., Perez Molina, J., & Garcia, M. E. (2002) · Journal of Clinical Microbiology

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 78

Linezolid therapy for infective endocarditis

Muñoz, P., Rodríguez-Creixéms, M., Moreno, M., Marín, M., Ramallo, V., Bouza, E., & GAME Study Group (2007) · Clinical Microbiology and Infection

Infective Endocarditis Diagnosis and ManagementSepsis Diagnosis and Treatment

Cited by 68

The role of antifungals against Candida biofilm in catheter-related candidemia

Bouza, E., Guinea, J., & Guembe, M. (2014) · Antibiotics

Antifungal resistance and susceptibilityInfective Endocarditis Diagnosis and Management

Cited by 62

The search for endocarditis in patients with candidemia: A systematic recommendation for echocardiography? A prospective cohort

on behalf of the GAME Study Group (Grupo de Apoyo al Manejo de la Endocarditis), Fernández-Cruz, A., Cruz Menárguez, M., Muñoz, P., Pedromingo, M., Peláez, T., Solís, J., Rodríguez-Créixems, M., & Bouza, E. (2015) · European Journal of Clinical Microbiology & Infectious Diseases

Infective Endocarditis Diagnosis and ManagementAntifungal resistance and susceptibility

Cited by 58

Incidence of Candidemia Is Higher in COVID-19 versus Non-COVID-19 Patients, but Not Driven by Intrahospital Transmission

Machado, M., Estévez, A., Sánchez-Carrillo, C., Guinea, J., Escribano, P., Alonso, R., Valerio, M., Padilla, B., Bouza, E., & Muñoz, P. (2022) · Journal of Fungi

Antifungal resistance and susceptibilityCOVID-19 Clinical Research Studies

Cited by 53

Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center.

Marcos-Zambrano, L. J., Escribano, P., Sánchez, C., Muñoz, P., Bouza, E., & Guinea, J. (2014) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 49

In Vitro Acquisition of Secondary Azole Resistance in Aspergillus fumigatus Isolates after Prolonged Exposure to Itraconazole: Presence of Heteroresistant Populations

Escribano, P., Recio, S., Peláez, T., González-Rivera, M., Bouza, E., & Guinea, J. (2012) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 48

The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp

Marcos-Zambrano, L. J., Gómez-Perosanz, M., Escribano, P., Bouza, E., & Guinea, J. (2017) · Journal of Antimicrobial Chemotherapy

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 44

Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?

Bassetti, M., Vena, A., Bouza, E., Peghin, M., Muñoz, P., Righi, E., Pea, F., Lackner, M., & Lass-Flörl, C. (2020) · Clinical Microbiology and Infection

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 40

Scope and frequency of fluconazole trailing assessed using EUCAST in invasive Candida spp. isolates

Marcos-Zambrano, L. J., Escribano, P., Sánchez-Carrillo, C., Bouza, E., & Guinea, J. (2016) · Medical Mycology

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 33

Biofilm production and antibiofilm activity of echinocandins and liposomal amphotericin B in echinocandin-resistant yeast species

Marcos-Zambrano, L. J., Gómez-Perosanz, M., Escribano, P., Zaragoza, O., Bouza, E., & Guinea, J. (2016) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 28

MSH2 Gene Point Mutations Are Not Antifungal Resistance Markers in Candida glabrata

Bordallo-Cardona, M. Á., Agnelli, C., Gómez-Nuñez, A., Sánchez-Carrillo, C., Bouza, E., Muñoz, P., Escribano, P., & Guinea, J. (2019) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 27

Two weeks of postsurgical therapy may be enough for high-risk cases of endocarditis caused by Streptococcus viridans or Streptococcus bovis

Muñoz, P., Giannella, M., Scoti, F., Predomingo, M., Puga, D., Pinto, A., Roda, J., Marin, M., & Bouza, E. (2012) · Clinical Microbiology and Infection

Infective Endocarditis Diagnosis and ManagementStreptococcal Infections and Treatments

Cited by 18